Intended for the detection of some frequently observed site mutations in seven genes which strongly implicate resistance to eight important first-line and second-line anti-tuberculosis drugs (rifampicin, isoniazid, streptomycin, ethambutol, fluoroquinolone, kanamycin, amikacin and capreomycin) in clinical isolate cultures and pulmonary smear-positive clinical specimens. There are 20 of the most frequently found mutations in these seven genes (rpoB, katG, inhA, rpsL, embB, gyrA and rrs).
bio-equip.cn
中文
